Alpha memo: resveratrol exercise training context boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The 'Why this is surprising' paragraph could briefly acknowledge that the two studies measure fundamentally different endpoints (intestinal ferroptosis/inflammation vs cardiovascular MAP), which is already implied but worth making explicit as the moderator axis.
• Title mentions 'context boundary' but the memo could one-line the specific moderator dimensions (species, organ endpoint, dose, age) more crisply.

Reviewer note

The memo delivers exactly what an alpha-memo should: one bounded, source-grounded research signal — that resveratrol + high-intensity exercise produces organ-protective effects in a murine intestinal model but may blunt a specific cardiovascular adaptation (MAP) in aged men. The title (resveratrol × exercise context boundary) aligns with both receipts: both study resveratrol co-administered with high-intensity exercise, and the contrast (murine intestinal protection vs human cardiovascular interference) is explicitly framed as a cross-context comparison rather than a single-anchor claim. Source grounding is strong. Receipt 1 (DOI 10.55730/1300-0144.5604, 2023) matches the described 28-day swimming protocol, 15 mg/kg/day resveratrol, intestinal inflammation/ferroptosis endpoints. Receipt 2 (DOI 10.1113/jphysiol.2013.258061, 2013) matches the described n=27 aged men, 250 mg/day trans-resveratrol, 8-week high-intensity training, MAP outcome. Both bundles contain abstracts that confirm the manuscript's claims about dose, design, and endpoint-specific findings. Claim-evidence alignment is proportionate. The memo uses appropriate hedging ('suggests,' 'hints,' 'may blunt') and explicitly bounds the human signal to one endpoint (MAP) rather than a global cardiovascular reversal. No clinical, policy, or investment claims are made. Limitations are specific and material: species, organ system, dose, duration, and population differences are enumerated, with a concrete falsifier (adequately powered trial showing no MAP/VO2max interaction). Gaps are actionable — the falsifier condition is testable. Synthesis is strong: the memo integrates the two receipts into a coherent moderator-boundary argument rather than a loose summary. The contrast structure (organ-protective in mice vs blunted adaptation in humans) is well-articulated. Accept. Bounded signal, directly receipt-backed, proportionate claims, explicit limits, no major issues.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis